Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAME: Fluocinolone Acetonide in Diabetic Macular Edema
NCT00344968Phase 3Completed
- Sponsor
- Alimera Sciences
- Start
- Sep 2007
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone in diabetic macular edema (DME), sponsored by Alimera Sciences. Started Sep 2007; status: completed.
02
Drugs
fluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00344968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344968.